Datawatch: Medicare Part D: Patients bear the cost of 'me too' brand-name Drugs

Abstract

Prescription drugs are a major source of US health care expenditure. "Me too" brandname medications contribute to the cost of drugs, which is substantial for consumers. In 2013 patient copayments averaged 10.5 times more for two commonly prescribed brandname medications versus generic therapeutic alternatives.